TW

Chiating Huang

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chiating Huang. Retrieved from https://idiyas.com/inventor/chiating-huang-olqy4zra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Chiating Huang - Innovator in Pharmaceutical Compositions

Introduction

Chiating Huang is a notable inventor based in Taiwan, recognized for his contributions to pharmaceutical compositions. His work primarily focuses on enhancing the solubility and bioavailability of specific compounds, which can have significant implications in medical treatments.

Latest Patents

Chiating Huang holds a patent titled "Compositions Comprising Inhibitors of Macrophage Elastase and Cyclodextrin." This invention provides formulations that combine a specific compound, 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidin-2,4-dione, with cyclodextrin and other excipients. The goal of this composition is to increase the water solubility and oral bioavailability of the compound, which may be beneficial in treating diseases such as asthma through the inhibition of matrix metalloproteinase -12. Currently, he has 0 patents.

Career Highlights

Chiating Huang is associated with Foresee Pharmaceuticals, LLC, where he applies his expertise in pharmaceutical development. His innovative approach to drug formulation has the potential to improve treatment options for various health conditions.

Collaborations

Chiating Huang collaborates with John Mao, contributing to the advancement of their projects within the pharmaceutical field.

Conclusion

Chiating Huang's work in developing compositions for enhanced drug solubility showcases his commitment to innovation in the pharmaceutical industry. His contributions may lead to significant advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…